JoyNatalieTsaiMD

Endocrinology • Boston, MA

Diabetes, Lipid Metabolism

Physician

Join to view full profile

Dr. Tsai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Tsai's full profile

Already have an account?

Office
50 Blossom St.
Thier 1051
Boston, MA 02114
Phone+1 617-726-6723

Fax+1 617-726-1703
Is this information wrong?

Education & Training

Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2011 - 2014
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2007 - 2010
Northwestern University The Feinberg School of MedicineClass of 2007

Certifications & Licensure

MA State Medical License 2014 - 2024
IL State Medical License 2007 - 2011

Publications & Presentations

PubMed

Correction to: The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial.
Joy N Tsai, Hang Lee, Grace Sassana-Khadka, Mackenzie Jordan, Savannah Ryan, Benjamin Z Leder, Ramchand, S.> ;Osteoporosis International. 2024 Feb 1
1 citations
The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial.
Joy N Tsai, Hang Lee, Grace Sassana-Khadka, Mackenzie Jordan, Savannah Ryan, Benjamin Z Leder, Ramchand, S.> ;Osteoporosis International. 2024 Feb 1
1 citations
The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA-HD Study Extension.
Natalie L David, Hang Lee, Michael Bruce, Mary L Bouxsein, Joy N Tsai, Benjamin Z Leder, Ramchand, S.> ;Journal of Bone and Mineral Research. 2023 Jan 1
16 citations
Efficacy of Zoledronic Acid in Maintaining Areal and Volumetric Bone Density After Combined Denosumab and Teriparatide Administration: DATA-HD Study Extension
Natalie L David, Hang Lee, Richard Eastell, Joy N. Tsai, Benjamin Z. Leder> ;Journal of Bone and Mineral Research. 2021 Feb 16
8 citations
Effects of Combination Denosumab and High-Dose Teriparatide Administration on Bone Microarchitecture and Estimated Strength: The DATA-HD HR-pQCT Study.
Natalie L David, Hang Lee, Michael Bruce, Mary L. Bouxsein, Benjamin Z. Leder, Joy N. Tsai> ;Journal of Bone and Mineral Research. 2021 Jan 1
7 citations
Bone Mineral Density Response With Denosumab in Combination With Standard or High-Dose Teriparatide: The DATA-HD RCT.
Natalie L David, Benjamin Z. Leder, Joy N. Tsai> ;The Journal of Clinical Endocrinology and Metabolism. 2020 Mar 1
3 citations
Hyperandrogenemia is Common in Asymptomatic Women and is Associated with Increased Metabolic Risk
Laura C. Torchen, Joy N. Tsai, Prathima Jasti, Rodrigo Macaya, Ryan Sisk, Matthew Dapas, M. Geoffrey Hayes, Margrit Urbanek, Andrea Dunaif> ;Obesity. 2020 Jan 1
30 citations
Cortical Bone Material Strength Index and Bone Microarchitecture in Postmenopausal Women With Atypical Femoral Fractures
Kristin L. Popp, Signe Caksa, Adriana Martinez-Betancourt, Amy Yuan, Joy N. Tsai, Elaine W. Yu, Mary L. Bouxsein> ;Journal of Bone and Mineral Research. 2019 Jan 1
34 citations
Bone Material Strength Index as Measured by Impact Microindentation in Postmenopausal Women With Distal Radius and Hip Fractures.
Tamara D. Rozental, Kempland C. Walley, Serkalem Demissie, Signe Caksa, Adriana Martinez-Betancourt, Amber M. Parker, Joy N. Tsai, Elaine W. Yu, Mary L. Bouxsein> ;Journal of Bone and Mineral Research. 2018 Apr 1
12 citations
Case 8-2018: A 55-Year-Old Woman with Shock and Labile Blood Pressure
Joseph Loscalzo, Nathalie Roy, Ravi V. Shah, Joy N. Tsai, Alexis M. Cahalane, Johannes Steiner, James R. Stone> ;The New England Journal of Medicine. 2018 Mar 14
21 citations
Effects of Teriparatide, Denosumab, or Both on Spine Trabecular Microarchitecture in DATA-Switch: a Randomized Controlled Trial
Joy N. Tsai, Linda A. Jiang, Hang Lee, Didier Hans, Benjamin Z. Leder> ;Journal of Clinical Densitometry. 2017 Oct 1
38 citations
Effects of Denosumab and Teriparatide Transitions on Bone Microarchitecture and Estimated Strength: the DATA-Switch HR-pQCT study: EFFECTS OF DENOSUMAB AND TERIPARATID...
Joy N. Tsai, Kyle K. Nishiyama, David Lin, Amy Yuan, Hang Lee, Mary L. Bouxsein, Benjamin Z. Leder> ;Journal of Bone and Mineral Research. 2017 Oct 1
68 citations
Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide Follow-up study (DATA-Follo...
Benjamin Z. Leder, Joy N. Tsai, Linda A. Jiang, Hang Lee> ;Bone. 2017 May 1
15 citations
Relationship between bone turnover and density with teriparatide, denosumab or both in women in the DATA study.
Joy N. Tsai, Sherri-Ann M. Burnett-Bowie, Hang Lee, Benjamin Z. Leder> ;Bone. 2017 Feb 1
175 citations
Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.
Matthew B. Greenblatt, Joy N. Tsai, Marc N. Wein> ;Clinical Chemistry. 2017 Feb 1
5 citations
Letter to the editor in response to the commentary, "Concurrent administration of PTH and antiresorptives: Additive effects or DXA cosmetics.
Benjamin Z. Leder, Joy N. Tsai, Sherri-Anne Burnett-Bowie, Mary L. Bouxsein, Robert M. Neer> ;Bone. 2016 Aug 1
21 citations
Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled T...
Benjamin Z. Leder, Joy N. Tsai, Robert M. Neer, Alexander V. Uihlein, Paul M. Wallace, Sherri-Ann M. Burnett-Bowie> ;Journal of Clinical Densitometry. 2016 Jul 1
72 citations
Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)
Joy N. Tsai, A. V. Uihlein, Sherri-Ann M. Burnett-Bowie, Robert M. Neer, Nicholas P. Derrico, Hang Lee, Mary L. Bouxsein, Benjamin Z. Leder> ;The Journal of Clinical Endocrinology and Metabolism. 2016 Mar 10
300 citations
Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
Benjamin Z. Leder, Joy N. Tsai, Alexander V. Uihlein, Paul M. Wallace, Hang Lee, Robert M. Neer, Sherri-Ann M. Burnett-Bowie> ;Lancet. 2015 Sep 19
5 citations
Comparative Resistance to Teriparatide-Induced Bone Resorption With Denosumab or Alendronate
Joy N. Tsai, Yuli Zhu, Katelyn Foley, Hang Lee, Sherri-Ann M. Burnett-Bowie, Robert M. Neer, Benjamin Z. Leder> ;The Journal of Clinical Endocrinology and Metabolism. 2015 May 1
100 citations
Comparative Effects of Teriparatide, Denosumab, and Combination Therapy on Peripheral Compartmental Bone Density, Microarchitecture, and Estimated Strength: the DATA‐H...
Joy N. Tsai, Alexander V. Uihlein, Sherri-Ann M. Burnett-Bowie, Robert M. Neer, Yuli Zhu, Nicholas P. Derrico, Hang Lee, Mary L. Bouxsein, Benjamin Z. Leder> ;Journal of Bone and Mineral Research. 2015 Jan 1
19 citations
Effects of escitalopram on markers of bone turnover: a randomized clinical trial.
Susan J. Diem, Hadine Joffe, Joseph C. Larson, Joy N. Tsai, Katherine A. Guthrie, Andrea Z. LaCroix, Kristine E. Ensrud, Ellen W. Freeman, Benjamin Z. Leder> ;The Journal of Clinical Endocrinology and Metabolism. 2014 Jul 11
179 citations
Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
Benjamin Z. Leder, Joy N. Tsai, Alexander V. Uihlein, Sherri-Ann M. Burnett-Bowie, Yuli Zhu, Katelyn Foley, Hang Lee, Robert M. Neer> ;The Journal of Clinical Endocrinology and Metabolism. 2014 Feb 11
301 citations
Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
Joy N. Tsai, Alexander V. Uihlein, Hang Lee, Ruchit Kumbhani, Erica Siwila-Sackman, Elizabeth A. McKay, Sherri-Ann M. Burnett-Bowie, Robert M. Neer, Benjamin Z. Leder> ;Lancet. 2013 Jul 6
Join now to see all

Lectures

Fracture Risk Assessment Beyond BMD and FRAX
ENDO 2019 - New Orleans, LA - 3/23/2019
Osteoporosis and Osteoporosis Therapies
ENDO 2019 - New Orleans, LA - 3/23/2019